Liver TX for hepatitis C cirrhosis in a low prevalence population: Risk factors and status at evaluation

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 5, 2006, Pages 592-596

  Melum, Espen ^a   Schrumpf, Erik ^a   Bjøro, Kristian ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Hepatitis C; Liver Transplantation; Norway; Risk factors

Indexed keywords

IMMUNOGLOBULIN G; INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; CAUCASIAN; CHILD; DRUG CONTAMINATION; FEMALE; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; NONHUMAN; NORWAY; PATIENT REFERRAL; PATIENT SCHEDULING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SURVIVAL RATE; TREATMENT INDICATION; VIRUS TRANSMISSION;

ADULT; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NORWAY; PREVALENCE; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646467813     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500347113     Document Type: Article

References (19)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96.
2. Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, et al. Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transplantation 2003;9:339-47.
3. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
4. Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transplantation 2003;9:796-804.
5. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003;38:864-70.
6. Anonymous. OPTN/SRTR Annual Report: transplant data 1993-2002. HHS/HRSA/SPB/DOT; UNOS; URREA. (Chapter VII). www.ustransplant.org. 2003.
7. Adam P, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. Evolution of liver transplantation in Europe: report of the European liver transplant registry. Liver Transplantation 2003;9:1231-43.
8. Scandiatransplant (www.scandiatransplant.org). 2005.
9. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin i Liver Dis 2000;20:17-35.
10. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.
11. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998;27:1717-22.
12. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two year after liver transplantation. Liver Transplantation 2003;9:117-3.
13. UNOS. MELD calculator. http://www.unos.org/waitlist/includes_local/pdfs/ meld_peld_calculator.pdf. 2004.
14. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogamma-globulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
15. Karman JF, Sileri P, Kamuda D, Cicalese L, Rastellini C, Wiley TE, et al. Risk factors for failure to meet listing requirements in liver transplant candidates with alcoholic cirrhosis. Transplantation 2001;71:1210-3.
16. Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000;35:861-5.
17. Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, et al. Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Scand J Infect Dis 1996;28:357-9.
18. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349(9055):825-32.
19. Bjøro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Froland SS. Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. Scand J Infect Dis 1998;30:520-2.